Kohei Doi

Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis

T. Takenobu, Shinsuke Yamamoto, H. Ikesue, 2021, Supportive Care in Cancer.

Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases

T. Takenobu, Shinsuke Yamamoto, H. Ikesue, 2021, Cancer Chemotherapy and Pharmacology.

Expression of Golgi membrane protein p138 is cell cycle-independent and dissociated from centrosome duplication.

Shohei Noma, F. Yamao, T. Yagura, 2002, Cell structure and function.